Open original FDA record ↗Recall record
- FDA identifier
- Z-0513-2020
- Company in FDA record
- Medline Industries Inc
- FDA record creation date
- Nov 22, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Incomplete seal and premature expiration of individually packaged Blood Glucose Test Strips.
Source facts
- Action
- Medline Industries, Inc. notified customers on about 09/18/2019, via "URGENT RECALL IMMEDIATE ACTION REQUIRED" letter. Customers were informed that the heat activated adhesive used to seal the foil pouch was not fully cured during the manufacturing process. As a result, an incomplete seal and premature expiration of the individually packaged Blood Glucose Test Strips has occurred. Inspection using EVENCARE G3 control solution and unused Blood Glucose Test Strips, from the affected lot, has shown that the test strips can produce inaccurate blood glucose readings. Instructions included to immediately check inventory for the affected item and lot number, quarantine affected product, complete and return the enclosed response form, arrange for the return of all affected product, and notify customers if the product was further distributed. Questions can be directed to 866-359-1704.
- Initiated
- 2019-09-18
- Root cause
- Packaging process control
- Terminated
- 2022-05-06
- Distribution
- Nationwide distribution to CA, CT, GA, ID, IL, IN, KS, MA, MI, MN, MO, MS, NV, OH, OR, SC, TN, TX, UT, WA, WI, WY.
- Recall number
- Z-0513-2020
- Recall status
- Terminated
- CDRH record ID
- 176684
- FDA record created
- 2019-11-22
- Recall event number
- 83890